FDA Inspection 989445 — GPT Pharmaceuticals Private Ltd

GPT Pharmaceuticals Private Ltd — FEI 3008311641

The FDA completed an inspection of GPT Pharmaceuticals Private Ltd on Jul 29, 2016 in Hyderabad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 29, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hyderabad (India)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented
200821 CFR 211.186(a)Written procedures followed
202721 CFR 211.192Investigations of discrepancies, failures
357121 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.